Pinnacle Financial Group, LLC
- SEC CIK
- 0001905962
- Latest filing
- Jul 30, 2026
XLO holding history
Xilio Therapeutics, Inc. in every 13F filed by Pinnacle Financial Group, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
XLO overviewAll 13F holders of XLOFull Q2 2026 holdings
- Shares (Q1 2026)
- 0
- Sold out in Q1 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 7
- Since Q2 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2026 | 0 | $0 | 0.0% | −714−100.0% | Sold outConverted for a 1-for-14 split | Holders |
| Q4 2025 | 10,000 | $6.40K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 10,000 | $8.43K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 10,000 | $6.80K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 10,000 | $7.24K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 10,000 | $9.55K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 10,000 | $7.88K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 10,000 | $9.47K | <0.1% | +10,000 | New | Holders |